EUVIMEDEUVIMED entdecken
Crossref

hsa-miR-9–FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis

Deepshikha Rathore, Vasundhara Dheer, Surbhi Singh, Shanaya Patel, Chirag Desai, Heena V Dave

Biochemical and Biophysical Research Communications · 2026-09 · 831 · 154342

DOI: 10.1016/j.bbrc.2026.154342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Deepshikha Rathore und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Science, Nirma University, Ahmedabad, Gujarat, India. Hauptthemen laut MEDLINE: MicroRNAs, Triple Negative Breast Neoplasms, Biomarkers, Tumor, Fatty Acid-Binding Protein 7. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastasis remains the primary cause of breast cancer mortality. Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype. It lacks targeted therapies and carries a high risk of metastasis. MiRNAs are one of the potential diagnostics and therapeutic biomarkers, given that the regulation of mRNA is critical for tumor growth and metastatic transformation of tumor cells. Identifying the differential expression of the miRNA-mRNA axis at the primary tumor site will provide novel molecular mechanisms for metastasis initiation. In this study, we applied an integrated approach to explore the metastasis-specific miRNA-mRNA regulatory axis in TNBC using TCGA-derived miRNA-seq and RNA-seq data. Differential expression analysis between metastatic and non-metastatic TNBC patient data identified 11 dysregulated miRNAs, of which 8 showed linear expression changes with increasing disease aggressiveness. Among them, hsa-miR-1-1/2, hsa-miR-9, and hsa-miR-1180 displayed strong diagnostic potential (AUC >0.8) and significant associations with overall survival in metastatic TNBC patients. Parallel RNA-seq analysis revealed 36 differentially expressed genes (DEGs). Target prediction highlighted that only hsa-miR-9-5p targeted three of the 36 DEGs-FABP7, GPR26, and UNC5D, where FABP7 demonstrated strong association with cancer pathways. The expression of these genes was also correlated with the overall survival of the TNBC patients. Validation of this axis in various breast cancer cells (metastatic and non-metastatic) was performed, and the results indicated an inverse expression pattern of hsa-miR-9-5p and FABP7, especially in metastatic TNBC cells. These findings propose the hsa-miR-9-FABP7 axis as a promising biomarker signature for predicting metastatic potential from primary TNBC tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsTriple Negative Breast NeoplasmsBiomarkers, TumorFatty Acid-Binding Protein 7HumansFemaleGene Expression Regulation, NeoplasticDisease ProgressionNeoplasm MetastasisCell Line, TumorPrognosisTumor Suppressor Proteins

Stichwörter der Autor:innen

MetastasisTriple-negative breast cancermiRNA-mRNA axis

Substanzen

MicroRNAsBiomarkers, TumorFatty Acid-Binding Protein 7FABP7 protein, humanMIRN92 microRNA, humanMIRN9 microRNA, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Institute of Science, Nirma University, Ahmedabad, Gujarat, India.
  • Division of Biological & Life Sciences, School of Arts & Sciences, Ahmedabad University, Ahmedabad, Gujarat, India.
  • Hemato Oncology Clinic, Vedanta Hospital, Ahmedabad, Gujarat, India.
  • Institute of Science, Nirma University, Ahmedabad, Gujarat, India. Electronic address: heena.dave@nirmauni.ac.in.

Förderung

  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Rathore, D., Dheer, V., Singh, S., Patel, S., Desai, C., & Dave, H. V. (2026). hsa-miR-9–FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis. Biochemical and Biophysical Research Communications, 831, 154342. https://doi.org/10.1016/j.bbrc.2026.154342

Vancouver

Rathore D, Dheer V, Singh S, Patel S, Desai C, Dave HV. hsa-miR-9–FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis. Biochemical and Biophysical Research Communications. 2026;831:154342. doi:10.1016/j.bbrc.2026.154342

BibTeX
@article{Rathore2026,
  author = {Rathore, Deepshikha and Dheer, Vasundhara and Singh, Surbhi and Patel, Shanaya and Desai, Chirag and Dave, Heena V},
  title = {hsa-miR-9–FABP7 axis as a predictive biomarker for metastatic progression in triple-negative breast cancer: An integrated analysis},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {831},
  pages = {154342},
  doi = {10.1016/j.bbrc.2026.154342}
}
Kostenlos starten →